Overview

Trial of S-1 Plus Cisplatin in Gastric Cancer

Status:
Unknown status

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effectiveness and safety of s-1 plus cisplatin versus 5-FU plus cisplatin as first-line therapy in the treatment of patients with advanced gastric cancer.

Phase:

Phase 3

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

Cisplatin
Tegafur